初诊危重急性髓系白血病患者的临床特征与预后分析
回顾性分析91例初诊危重急性髓系白血病(AML)患者收住血液专科重症监护病房(HCU)的临床特征,肺部感染为最主要入住原因(78.0%),35例(38.5%)在入HCU后28天内死亡,弥散性血管内凝血(DIC)、脓毒症及心功能不全是28天死亡的独立危险因素。
要点
- 初诊危重AML患者入住HCU的主要原因为肺部感染(78.0%),其次为呼吸衰竭(44.0%)。
- 接受诱导化疗的患者复合完全缓解率为65.4%,总体缓解率为88.5%。
- 35例(38.5%)患者在入HCU后28天内死亡,DIC、脓毒症及心功能不全是独立危险因素。
核心结论
- 初诊危重AML患者入住HCU的主要原因为肺部感染,近四成患者早期死亡,DIC、脓毒症及心功能不全是影响早期死亡的因素。
研究设计与样本
- 回顾性分析2020年10月至2024年10月苏州大学附属第一医院HCU收治的91例初诊AML患者的临床资料。
主要发现
- 初诊AML患者从诊断至入HCU的中位时间为3(3, 9)天,中位住HCU天数为10(3, 23)天。
- 71例患者在诱导化疗前收住HCU,20例在诱导化疗开始后转入HCU。
- 收入HCU的最主要原因为肺部感染(78.0%),其次分别为呼吸衰竭(44.0%)、肝功能不全(28.6%)、肾功能不全(27.5%)、DIC(25.3%)和脓毒症(23.1%)。
- 入HCU时中位APACHE Ⅱ评分为14(11, 18)分,中位SOFA评分为7(4, 10)分。
- 接受诱导化疗的患者复合完全缓解率及总体缓解率分别为65.4%和88.5%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: This study retrospectively analyzed the clinical characteristics of patients newly diagnosed with acute myeloid leukemia (AML) who were admitted to the hematology intensive care unit (HCU) with critical illness. It also examined factors associated with critical illness and early mortality in these patients. Methods: Clinical data were collected from 91 newly diagnosed AML patients admitted to the HCU of the Department of Hematology, First Affiliated Hospital of Soochow University, from October 2020 to 2024. Reasons for HCU admission, major therapeutic interventions, and risk factors for critical illness and early mortality were analyzed. Results: The median time from diagnosis to HCU admission was 3 days (IQR: 3-9 days), and the median HCU stay was 10 days (IQR: 3-23 days). Of the 91 patients, 71 were admitted to the HCU before induction chemotherapy, while 20 were transferred to the HCU after its initiation. The leading causes of HCU admission were pulmonary infection (78.0% ), respiratory failure (44.0% ), hepatic insufficiency (28.6% ), renal insufficiency (27.5% ), disseminated intravascular coagulation (DIC; 25.3% ), and sepsis (23.1% ). Median Acute Physiology and Chronic Health Evaluation Ⅱ (APACHE Ⅱ) and SOFA scores at HCU admission were 14 (IQR: 11-18) and the median Sepsis Related Organ Failure Assessment (SOFA) score was 7 (IQR: 4, 10). Major HCU interventions included vasoactive drugs, noninvasive and invasive mechanical ventilation, continuous renal replacement therapy, therapeutic leukocyte clearance, and cardiopulmonary resuscitation. Among patients receiving induction chemotherapy, the composite complete remission rate was 65.4%, and the overall remission rate was 88.5%. Thirty-five (38.5% ) patients died within 28 days of HCU admission. Independent risk factors for 28-day mortality were DIC (OR=9.350, 95% CI 1.999-43.745, P=0.005), sepsis (OR=6.817, 95% CI 1.571-29.582, P=0.010), and cardiac insufficiency (OR=12.281, 95% CI 2.385-63.254, P=0.003) . Conclusion: The main reason for HCU admission in newly diagnosed critically ill AML patients was pulmonary infection. Nearly 40% of patients experisenced early death, and DIC, sepsis, and heart failure were factors influencing early mortatlity. 目的: 回顾性分析初诊危重急性髓系白血病(AML)收住血液专科重症监护病房(HCU)患者的临床特征,分析AML危重症出现的特点和早期死亡相关因素。 方法: 收集2020年10月至2024年10月苏州大学附属第一医院HCU收治的91例初诊AML患者的临床资料,分析患者收住HCU的原因及HCU的主要治疗措施,分析危重患者早期死亡的危险因素。 结果: 初诊AML患者从诊断至入HCU的中位时间为3(3, 9)d,中位住HCU天数为10(3, 23)d,71例患者在诱导化疗前收住HCU,20例在诱导化疗开始后转入HCU。收入HCU的最主要原因为肺部感染(78.0%),其次分别是呼吸衰竭(44.0%)、肝功能不全(28.6%)、肾功能不全(27.5%)、弥散性血管内凝血(DIC)(25.3%)和脓毒症(23.1%),入HCU时中位急性生理与慢性健康Ⅱ评分(APACHE Ⅱ评分)14(11, 18)分,中位脓毒症序贯器官衰竭评分(SOFA评分)7(4, 10)分,HCU的主要救治措施包括血管活性药物、无创机械通气、连续性肾脏替代治疗、有创机械通气及治疗性白细胞清除。接受诱导化疗的患者复合完全缓解率及总体缓解率分别为65.4%和88.5%。35例(38.5%)患者在入HCU后28 d内死亡,DIC(OR=9.350,95%CI 1.999~43.745,P=0.005)、脓毒症(OR=6.817,95%CI 1.571~29.582,P=0.010)及心功能不全(OR=12.281,95%CI 2.385~63.254,P=0.003)是患者28 d死亡的独立危险因素。 结论: 初诊危重AML患者入住HCU的主要原因为肺部感染,近四成患者早期死亡,DIC、脓毒症及心功能不全是影响早期死亡的因素。.
引用
- Liang PQ, Gao M, Xie Y, et al. [Clinical characteristics and prognostic analysis of newly diagnosed acute myeloid leukemia with critical illness]. Zhonghua Xue Ye Xue Za Zhi. 2025. PMID: 40059680. doi:10.3760/cma.j.cn121090-20241211-00561
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。